ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

CALG Loses Pediatrics Grant

July 20, 1979

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010